治療用RNAiの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2021)

【英語タイトル】Global RNAi for Therapeutic Market by Manufacturers, Regions, Type and Application, Forecast to 2021

GlobalInfoResearchが出版した調査資料(GIR703031829)・商品コード:GIR703031829
・発行会社(調査会社):GlobalInfoResearch
・発行日:2016年11月7日
・ページ数:116
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD3,480 ⇒換算¥361,920見積依頼/購入/質問フォーム
Corporate UserUSD4,680 ⇒換算¥486,720見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、治療用RNAiの世界市場について調査・分析し、治療用RNAiの世界市場概観、メーカー動向、メーカー別治療用RNAiシェア、市場規模推移、市場規模予測、治療用RNAi種類別分析(siRNA、miRNA、shRNA)、治療用RNAi用途別分析(がん、循環器、HBV、その他)、主要地域分析(北米、欧州、アジア)、主要国分析データなどを含め、以下の構成でお届け致します。
・治療用RNAiの市場概観
・治療用RNAiのメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・治療用RNAiのメーカー別販売動向、市場シェア、市場集中度、競争動向
・治療用RNAiの世界市場規模
・治療用RNAiの北米市場分析(アメリカ、カナダ、メキシコ等)
・治療用RNAiのアメリカ市場規模推移
・治療用RNAiのカナダ市場規模推移
・治療用RNAiのメキシコ市場規模推移
・治療用RNAiのヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・治療用RNAiのドイツ市場規模推移
・治療用RNAiのイギリス市場規模推移
・治療用RNAiのロシア市場規模推移
・治療用RNAiのアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・治療用RNAiの日本市場規模推移
・治療用RNAiの中国市場規模推移
・治療用RNAiの韓国市場規模推移
・治療用RNAiのインド市場規模推移
・治療用RNAiの東南アジア市場規模推移
・治療用RNAiの南米・中東・アフリカ市場分析
・治療用RNAiの種類別分析/市場規模推移(siRNA、miRNA、shRNA)
・治療用RNAiの用途別分析/市場規模推移(がん、循環器、HBV、その他)
・治療用RNAiの市場予測(地域別予測、種類別予測、用途別予測)
・治療用RNAiの販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.

Scope of the Report:
This report focuses on the RNAi for Therapeutic in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Alnylam Pharmaceuticals
Arbutus Biopharma (Tekmira)
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
Silence Therapeutics
Benitec Biopharma
miRagen Therapeutics
Sylentis
Gradalis
Sirnaomics
Silenseed

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America, Middle East and Africa

Market Segment by Type, covers
siRNA
miRNA
shRNA

Market Segment by Applications, can be divided into
Cancer
Cardiovascular
HBV
Other

There are 13 Chapters to deeply display the global RNAi for Therapeutic market.

Chapter 1, to describe RNAi for Therapeutic Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of RNAi for Therapeutic, with sales, revenue, and price of RNAi for Therapeutic, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4, to show the global market by regions, with sales, revenue and market share of RNAi for Therapeutic, for each region, from 2011 to 2016;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 11, RNAi for Therapeutic market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;

Chapter 12 and 13, to describe RNAi for Therapeutic sales channel, distributors, traders, dealers, appendix and data source.

【レポートの目次】

Table of Contents

Global RNAi for Therapeutic Market by Manufacturers, Regions, Type and Application, Forecast to 2021
1 Market Overview
1.1 RNAi for Therapeutic Introduction
1.2 Market Analysis by Type
1.2.1 siRNA
1.2.2 miRNA
1.2.3 shRNA
1.3 Market Analysis by Applications
1.3.1 Cancer
1.3.2 Cardiovascular
1.3.3 HBV
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA
1.4.1.2 Canada
1.4.1.3 Mexico
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany
1.4.2.2 France
1.4.2.3 UK
1.4.2.4 Russia
1.4.2.5 Italy
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China
1.4.3.2 Japan
1.4.3.3 Korea
1.4.3.4 India
1.4.3.5 Southeast Asia
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil
1.4.4.2 Egypt
1.4.4.3 Saudi Arabia
1.4.4.4 South Africa
1.4.4.5 Nigeria
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Alnylam Pharmaceuticals
2.1.1 Business Overview
2.1.2 RNAi for Therapeutic Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.2 Arbutus Biopharma (Tekmira)
2.2.1 Business Overview
2.2.2 RNAi for Therapeutic Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.3 Arrowhead
2.3.1 Business Overview
2.3.2 RNAi for Therapeutic Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Arrowhead RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.4 Dicerna Pharmaceuticals
2.4.1 Business Overview
2.4.2 RNAi for Therapeutic Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.5 Mirna Therapeutics
2.5.1 Business Overview
2.5.2 RNAi for Therapeutic Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Mirna Therapeutics RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.6 Quark Pharmaceuticals
2.6.1 Business Overview
2.6.2 RNAi for Therapeutic Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Quark Pharmaceuticals RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.7 RXi Pharmaceuticals
2.7.1 Business Overview
2.7.2 RNAi for Therapeutic Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 RXi Pharmaceuticals RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.8 Silence Therapeutics
2.8.1 Business Overview
2.8.2 RNAi for Therapeutic Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Silence Therapeutics RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.9 Benitec Biopharma
2.9.1 Business Overview
2.9.2 RNAi for Therapeutic Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Benitec Biopharma RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.10 miRagen Therapeutics
2.10.1 Business Overview
2.10.2 RNAi for Therapeutic Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 miRagen Therapeutics RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.11 Sylentis
2.11.1 Business Overview
2.11.2 RNAi for Therapeutic Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Sylentis RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.12 Gradalis
2.12.1 Business Overview
2.12.2 RNAi for Therapeutic Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Gradalis RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.13 Sirnaomics
2.13.1 Business Overview
2.13.2 RNAi for Therapeutic Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Sirnaomics RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.14 Silenseed
2.14.1 Business Overview
2.14.2 RNAi for Therapeutic Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Silenseed RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
3 Global RNAi for Therapeutic Market Competition, by Manufacturer
3.1 Global RNAi for Therapeutic Sales and Market Share by Manufacturer
3.2 Global RNAi for Therapeutic Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 RNAi for Therapeutic Manufacturer Market Share
3.3.2 Top 6 RNAi for Therapeutic Manufacturer Market Share
3.4 Market Competition Trend
4 Global RNAi for Therapeutic Market Analysis by Regions
4.1 Global RNAi for Therapeutic Sales, Revenue and Market Share by Regions
4.1.1 Global RNAi for Therapeutic Sales by Regions (2011-2016)
4.1.2 Global RNAi for Therapeutic Revenue by Regions (2011-2016)
4.2 North America RNAi for Therapeutic Sales and Growth (2011-2016)
4.3 Europe RNAi for Therapeutic Sales and Growth (2011-2016)
4.4 Asia-Pacific RNAi for Therapeutic Sales and Growth (2011-2016)
4.5 South America RNAi for Therapeutic Sales and Growth (2011-2016)
4.6 Middle East and Africa RNAi for Therapeutic Sales and Growth (2011-2016)
5 North America RNAi for Therapeutic by Countries
5.1 North America RNAi for Therapeutic Sales, Revenue and Market Share by Countries
5.1.1 North America RNAi for Therapeutic Sales by Countries (2011-2016)
5.1.2 North America RNAi for Therapeutic Revenue by Countries (2011-2016)
5.2 USA RNAi for Therapeutic Sales and Growth (2011-2016)
5.3 Canada RNAi for Therapeutic Sales and Growth (2011-2016)
5.4 Mexico RNAi for Therapeutic Sales and Growth (2011-2016)
6 Europe RNAi for Therapeutic by Countries
6.1 Europe RNAi for Therapeutic Sales, Revenue and Market Share by Countries
6.1.1 Europe RNAi for Therapeutic Sales by Countries (2011-2016)
6.1.2 Europe RNAi for Therapeutic Revenue by Countries (2011-2016)
6.2 Germany RNAi for Therapeutic Sales and Growth (2011-2016)
6.3 UK RNAi for Therapeutic Sales and Growth (2011-2016)
6.4 France RNAi for Therapeutic Sales and Growth (2011-2016)
6.5 Russia RNAi for Therapeutic Sales and Growth (2011-2016)
6.6 Italy RNAi for Therapeutic Sales and Growth (2011-2016)
7 Asia-Pacific RNAi for Therapeutic by Countries
7.1 Asia-Pacific RNAi for Therapeutic Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific RNAi for Therapeutic Sales by Countries (2011-2016)
7.1.2 Asia-Pacific RNAi for Therapeutic Revenue by Countries (2011-2016)
7.2 China RNAi for Therapeutic Sales and Growth (2011-2016)
7.3 Japan RNAi for Therapeutic Sales and Growth (2011-2016)
7.4 Korea RNAi for Therapeutic Sales and Growth (2011-2016)
7.5 India RNAi for Therapeutic Sales and Growth (2011-2016)
7.6 Southeast Asia RNAi for Therapeutic Sales and Growth (2011-2016)
8 South America, Middle East and Africa RNAi for Therapeutic by Countries
8.1 South America, Middle East and Africa RNAi for Therapeutic Sales, Revenue and Market Share by Countries
8.1.1 South America, Middle East and Africa RNAi for Therapeutic Sales by Countries (2011-2016)
8.1.2 South America, Middle East and Africa RNAi for Therapeutic Revenue by Countries (2011-2016)
8.2 Brazil RNAi for Therapeutic Sales and Growth (2011-2016)
8.3 Saudi Arabia RNAi for Therapeutic Sales and Growth (2011-2016)
8.4 Egypt RNAi for Therapeutic Sales and Growth (2011-2016)
8.5 Nigeria RNAi for Therapeutic Sales and Growth (2011-2016)
8.6 South Africa RNAi for Therapeutic Sales and Growth (2011-2016)
9 RNAi for Therapeutic Market Segment by Type
9.1 Global RNAi for Therapeutic Sales, Revenue and Market Share by Type (2011-2016)
9.1.1 Global RNAi for Therapeutic Sales and Market Share by Type (2011-2016)
9.1.2 Global RNAi for Therapeutic Revenue and Market Share by Type (2011-2016)
9.2 siRNA Sales Growth and Price
9.2.1 Global siRNA Sales Growth (2011-2016)
9.2.2 Global siRNA Price (2011-2016)
9.3 miRNA Sales Growth and Price
9.3.1 Global miRNA Sales Growth (2011-2016)
9.3.2 Global miRNA Price (2011-2016)
9.4 shRNA Sales Growth and Price
9.4.1 Global shRNA Sales Growth (2011-2016)
9.4.2 Global shRNA Price (2011-2016)
10 RNAi for Therapeutic Market Segment by Application
10.1 Global RNAi for Therapeutic Sales Market Share by Application (2011-2016)
10.2 Cancer Sales Growth (2011-2016)
10.3 Cardiovascular Sales Growth (2011-2016)
10.4 HBV Sales Growth (2011-2016)
10.5 Other Sales Growth (2011-2016)
11 RNAi for Therapeutic Market Forecast (2016-2021)
11.1 Global RNAi for Therapeutic Sales, Revenue and Growth Rate (2016-2021)
11.2 RNAi for Therapeutic Market Forecast by Regions (2016-2021)
11.3 RNAi for Therapeutic Market Forecast by Type (2016-2021)
11.4 RNAi for Therapeutic Market Forecast by Application (2016-2021)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Future Trend
12.2 Distributors, Traders and Dealers
13 Appendix
13.1 Methodology
13.2 Analyst Introduction
13.3 Data Source

List of Tables and Figures
Figure RNAi for Therapeutic Picture
Figure Global Sales Market Share of RNAi for Therapeutic by Types in 2015
Table RNAi for Therapeutic Types for Major Manufacturers
Figure siRNA Picture
Figure miRNA Picture
Figure shRNA Picture
Table RNAi for Therapeutic Sales Market Share by Applications in 2015
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table Alnylam Pharmaceuticals RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Arbutus Biopharma (Tekmira) Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table Arbutus Biopharma (Tekmira) RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Arrowhead Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table Arrowhead RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Dicerna Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table Dicerna Pharmaceuticals RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Mirna Therapeutics Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table Mirna Therapeutics RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Quark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table Quark Pharmaceuticals RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table RXi Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RXi Pharmaceuticals RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Silence Therapeutics Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table Silence Therapeutics RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Benitec Biopharma Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table Benitec Biopharma RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table miRagen Therapeutics Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table miRagen Therapeutics RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Sylentis Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table Sylentis RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Gradalis Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table Gradalis RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Sirnaomics Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table Sirnaomics RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Silenseed Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table Silenseed RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Basic Information, Manufacturing Base and Competitors
Table RNAi for Therapeutic Type and Applications
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2015-2016)
Table Global RNAi for Therapeutic Sales by Manufacturer (2015-2016)
Figure Global RNAi for Therapeutic Sales Market Share by Manufacturer in 2015
Figure Global RNAi for Therapeutic Sales Market Share by Manufacturer in 2016
Table Global RNAi for Therapeutic Revenue by Manufacturer (2015-2016)
Figure Global RNAi for Therapeutic Revenue Market Share by Manufacturer in 2015
Figure Global RNAi for Therapeutic Revenue Market Share by Manufacturer in 2016
Figure Global RNAi for Therapeutic Sales and Growth (2011-2016)
Figure Global RNAi for Therapeutic Revenue and Growth (2011-2016)
Table Global RNAi for Therapeutic Sales by Regions (2011-2016)
Table Global RNAi for Therapeutic Sales Market Share by Regions (2011-2016)
Table Global RNAi for Therapeutic Revenue by Regions (2011-2016)
Table Global RNAi for Therapeutic Revenue Market Share by Regions (2011-2016)
Figure North America RNAi for Therapeutic Sales and Growth (2011-2016)
Figure Europe RNAi for Therapeutic Sales and Growth (2011-2016)
Figure Asia-Pacific RNAi for Therapeutic Sales and Growth (2011-2016)
Figure South America RNAi for Therapeutic Sales and Growth (2011-2016)
Figure Middle East and Africa RNAi for Therapeutic Sales and Growth (2011-2016)
Figure North America RNAi for Therapeutic Revenue and Growth (2011-2016)
Table North America RNAi for Therapeutic Sales by Countries (2011-2016)
Table North America RNAi for Therapeutic Sales Market Share by Countries (2011-2016)
Table North America RNAi for Therapeutic Revenue by Countries (2011-2016)
Table North America RNAi for Therapeutic Revenue Market Share by Countries (2011-2016)
Figure USA RNAi for Therapeutic Sales and Growth (2011-2016)
Figure Canada RNAi for Therapeutic Sales and Growth (2011-2016)
Figure Mexico RNAi for Therapeutic Sales and Growth (2011-2016)
Figure Europe RNAi for Therapeutic Revenue and Growth (2011-2016)
Table Europe RNAi for Therapeutic Sales by Countries (2011-2016)
Table Europe RNAi for Therapeutic Sales Market Share by Countries (2011-2016)
Table Europe RNAi for Therapeutic Revenue by Countries (2011-2016)
Table Europe RNAi for Therapeutic Revenue Market Share by Countries (2011-2016)
Figure Germany RNAi for Therapeutic Sales and Growth (2011-2016)
Figure UK RNAi for Therapeutic Sales and Growth (2011-2016)
Figure France RNAi for Therapeutic Sales and Growth (2011-2016)
Figure Russia RNAi for Therapeutic Sales and Growth (2011-2016)
Figure Italy RNAi for Therapeutic Sales and Growth (2011-2016)
Figure Asia-Pacific RNAi for Therapeutic Revenue and Growth (2011-2016)
Table Asia-Pacific RNAi for Therapeutic Sales by Countries (2011-2016)
Table Asia-Pacific RNAi for Therapeutic Sales Market Share by Countries (2011-2016)
Table Asia-Pacific RNAi for Therapeutic Revenue by Countries (2011-2016)
Table Asia-Pacific RNAi for Therapeutic Revenue Market Share by Countries (2011-2016)
Figure China RNAi for Therapeutic Sales and Growth (2011-2016)
Figure Japan RNAi for Therapeutic Sales and Growth (2011-2016)
Figure Korea RNAi for Therapeutic Sales and Growth (2011-2016)
Figure India RNAi for Therapeutic Sales and Growth (2011-2016)
Figure Southeast Asia RNAi for Therapeutic Sales and Growth (2011-2016)
Figure South America, Middle East and Africa RNAi for Therapeutic Revenue and Growth (2011-2016)
Table South America, Middle East and Africa RNAi for Therapeutic Sales by Countries (2011-2016)
Table South America, Middle East and Africa RNAi for Therapeutic Sales Market Share by Countries (2011-2016)
Table South America, Middle East and Africa RNAi for Therapeutic Revenue by Countries (2011-2016)
Table South America, Middle East and Africa RNAi for Therapeutic Revenue Market Share by Countries (2011-2016)
Figure Brazil RNAi for Therapeutic Sales and Growth (2011-2016)
Figure Saudi Arabia RNAi for Therapeutic Sales and Growth (2011-2016)
Figure Egypt RNAi for Therapeutic Sales and Growth (2011-2016)
Figure Nigeria RNAi for Therapeutic Sales and Growth (2011-2016)
Figure South Africa RNAi for Therapeutic Sales and Growth (2011-2016)
Table Global RNAi for Therapeutic Sales by Type (2011-2016)
Table Global RNAi for Therapeutic Sales Share by Type (2011-2016)
Table Global RNAi for Therapeutic Revenue by Type (2011-2016)
Table Global RNAi for Therapeutic Revenue Share by Type (2011-2016)
Figure Global siRNA Sales Growth (2011-2016)
Figure Global siRNA Price (2011-2016)
Figure Global miRNA Sales Growth (2011-2016)
Figure Global miRNA Price (2011-2016)
Figure Global shRNA Sales Growth (2011-2016)
Figure Global shRNA Price (2011-2016)
Table Global RNAi for Therapeutic Sales by Application (2011-2016)
Table Global RNAi for Therapeutic Sales Share by Application (2011-2016)
Figure Global Cancer Sales Growth (2011-2016)
Figure Global Cardiovascular Sales Growth (2011-2016)
Figure Global HBV Sales Growth (2011-2016)
Figure Global Other Sales Growth (2011-2016)
Figure Global RNAi for Therapeutic Sales, Revenue and Growth Rate (2016 -2021)
Table Global RNAi for Therapeutic Sales Forecast by Regions (2016-2021)
Table Global RNAi for Therapeutic Market Share Forecast by Regions (2016-2021)
Table Global RNAi for Therapeutic Sales Forecast by Type (2016-2021)
Table Global RNAi for Therapeutic Market Share Forecast by Type (2016-2021)
Table Global RNAi for Therapeutic Sales Forecast by Application (2016-2021)
Table Global RNAi for Therapeutic Market Share Forecast by Application (2016-2021)
Table Distributors/Traders/ Dealers List

【レポートのキーワード】

治療用RNAi、siRNA、miRNA、shRNA、がん、循環器、HBV

★調査レポート[治療用RNAiの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2021)] (コード:GIR703031829)販売に関する免責事項を必ずご確認ください。
★調査レポート[治療用RNAiの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2021)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆